109 related articles for article (PubMed ID: 16190757)
21. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
22. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
[TBL] [Abstract][Full Text] [Related]
23. The flavivirus polymerase as a target for drug discovery.
Malet H; Massé N; Selisko B; Romette JL; Alvarez K; Guillemot JC; Tolou H; Yap TL; Vasudevan S; Lescar J; Canard B
Antiviral Res; 2008 Oct; 80(1):23-35. PubMed ID: 18611413
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore identification of Raf-1 kinase inhibitors.
Zhu T; Jiao Y; Chen YD; Wang X; Li HF; Zhang LY; Lu T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2346-50. PubMed ID: 18346893
[TBL] [Abstract][Full Text] [Related]
26. 2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.
Park HR; Park KS; Chong Y
Bioorg Med Chem Lett; 2011 Jun; 21(11):3202-5. PubMed ID: 21543225
[TBL] [Abstract][Full Text] [Related]
27. Structure-based inhibition of Norovirus RNA-dependent RNA polymerases.
Mastrangelo E; Pezzullo M; Tarantino D; Petazzi R; Germani F; Kramer D; Robel I; Rohayem J; Bolognesi M; Milani M
J Mol Biol; 2012 Jun; 419(3-4):198-210. PubMed ID: 22446684
[TBL] [Abstract][Full Text] [Related]
28. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
Tsantrizos YS
Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
[TBL] [Abstract][Full Text] [Related]
29. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
[TBL] [Abstract][Full Text] [Related]
30. Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.
Zeng LF; Zhang HS; Wang YH; Sanchez T; Zheng YT; Neamati N; Long YQ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4521-4. PubMed ID: 18662877
[TBL] [Abstract][Full Text] [Related]
31. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
Krovat EM; Langer T
J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
[TBL] [Abstract][Full Text] [Related]
32. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes.
Bacchi A; Biemmi M; Carcelli M; Carta F; Compari C; Fisicaro E; Rogolino D; Sechi M; Sippel M; Sotriffer CA; Sanchez TW; Neamati N
J Med Chem; 2008 Nov; 51(22):7253-64. PubMed ID: 18983138
[TBL] [Abstract][Full Text] [Related]
33. Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
Popovici-Muller J; Shipps GW; Rosner KE; Deng Y; Wang T; Curran PJ; Brown MA; Siddiqui MA; Cooper AB; Duca J; Cable M; Girijavallabhan V
Bioorg Med Chem Lett; 2009 Nov; 19(22):6331-6. PubMed ID: 19819138
[TBL] [Abstract][Full Text] [Related]
34. A three-dimensional pharmacophore model for IMPDH inhibitors.
Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
[TBL] [Abstract][Full Text] [Related]
35. A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.
Kotsikorou E; Oldfield E
J Med Chem; 2003 Jul; 46(14):2932-44. PubMed ID: 12825934
[TBL] [Abstract][Full Text] [Related]
36. A specific pharmacophore model of Aurora B kinase inhibitors and virtual screening studies based on it.
Wang HY; Li LL; Cao ZX; Luo SD; Wei YQ; Yang SY
Chem Biol Drug Des; 2009 Jan; 73(1):115-26. PubMed ID: 19152640
[TBL] [Abstract][Full Text] [Related]
37. N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase.
Yin Z; Chen YL; Kondreddi RR; Chan WL; Wang G; Ng RH; Lim JY; Lee WY; Jeyaraj DA; Niyomrattanakit P; Wen D; Chao A; Glickman JF; Voshol H; Mueller D; Spanka C; Dressler S; Nilar S; Vasudevan SG; Shi PY; Keller TH
J Med Chem; 2009 Dec; 52(24):7934-7. PubMed ID: 20014868
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
Li X; Vince R
Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
[TBL] [Abstract][Full Text] [Related]
39. Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture.
Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Baker A; Earnshaw DL; Hofmann GA; Keenan RM; Dhanak D
Bioorg Med Chem Lett; 2005 Mar; 15(6):1553-6. PubMed ID: 15745795
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors.
Equbal T; Silakari O; Rambabu G; Ravikumar M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1594-600. PubMed ID: 17236767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]